Search

Displaying all 2 results
DrugBest match

Obiltoxaximab

go.drugbank.com/drugs/DB05336
Approved

Obiltoxaximab, an affinity-enhanced monoclonal antibody (Mab), is used for prevention and treatment of infection and death caused by anthrax toxin. Obiltoxaximab is a chimeric IgG1 kappa monoclonal antibody (mAb) that binds the PA component of B. anthracis toxin. It has an approximate molecular weight of 148 kDa.

  1. Indication

    Inhalational Anthrax

    go.drugbank.com/conditions/DBCOND0065198
    Drugs: Anthrax immune globulin human · Cethromycin · Ciprofloxacin · Doxycycline · Levofloxacin · Obiltoxaximab +1 more